Pharmacology of vagal afferent influences on disordered breathing during sleep

Respiratory Physiology and Neurobiology

Volumn 164, Issue 1-2, 2008, Pages 197-203

  Carley, David W ^a   Radulovacki, Miodrag ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Animal Model; Neuromodulation; Rapid eye movement; Respiratory disturbance index; Respiratory reflex; Sleep related breathing disorders

Indexed keywords

CANNABINOID RECEPTOR AGONIST; CAPSAICIN; ITRIGLUMIDE; KETANSERIN; LOSARTAN; MIRTAZAPINE; OLEAMIDE; ONDANSETRON; PROTOVERATRINE; SEROTONIN; SEROTONIN 3 ANTAGONIST; ZACOPRIDE;

ANIMAL MODEL; ARTICLE; BREATHING REFLEX; CENTRAL SLEEP APNEA SYNDROME; CONTINUOUS INFUSION; DRUG DOSE COMPARISON; DRUG WITHDRAWAL; FEEDBACK SYSTEM; HUMAN; INCREASED APPETITE; NEUROCHEMISTRY; NEUROMODULATION; NODOSE GANGLION; NONHUMAN; PRIORITY JOURNAL; SEDATION; SENSORY NERVE CONDUCTION; SIDE EFFECT; SINGLE DRUG DOSE; VAGUS NERVE; VAGUS NERVE STIMULATION;

ANIMALS; HUMANS; SLEEP APNEA SYNDROMES; VAGUS NERVE;

EID: 53849134101     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2008.06.021     Document Type: Article

References (51)

1. Anon. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22 (1999) 667-689
2. Arens R., and Marcus C.L. Pathophysiology of upper airway obstruction: a developmental perspective. Sleep 27 (2004) 997-1019
3. Ashby B. Co-expression of prostaglandin receptors with opposite effects: a model for homeostatic control of autocrine and paracrine signaling. Biochem. Pharmacol. 55 (1998) 239-246
4. Bender F.L., Mederos Y.S.M., Li Y., Ji A., Weihe E., Gudermann T., and Schafer M.K. The temperature-sensitive ion channel TRPV2 is endogenously expressed and functional in the primary sensory cell line F-11. Cell. Physiol. Biochem. 15 (2005) 183-194
5. Browning K.N. Excitability of nodose ganglion cells and their role in vago-vagal reflex control of gastrointestinal function. Curr. Opin. Pharmacol. 3 (2003) 613-617
6. Bulow K. Respiration and wakefulness in man. Acta Physiol. Scand. 59 (1963) 1-110
7. 4 agonist, reduces sleep apneas in rats. Pharmacol. Biochem. Behav. 69 (2001) 283-289
8. Carley D.W., Olopade C., Ruigt G.S., and Radulovacki M. Efficacy of mirtazapine in obstructive sleep apnea syndrome. Sleep 30 (2007) 35-41
9. Carley D.W., Paviovic S., Janelidze M., and Radulovacki M. Functional role for cannabinoids in respiratory stability during sleep. Sleep 25 (2002) 391-398
10. Carley D.W., Pavlovic S., Malis M., Knezevic N., Saponjic J., Li C., and Radulovacki M. C-fiber activation exacerbates sleep-disordered breathing in rats. Sleep Breath 8 (2004) 147-154
11. Carley D.W., and Radulovacki M. Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat. Am. J. Respir. Crit. Care Med. 160 (1999) 1824-1829
12. Carley D.W., and Radulovacki M. Role of peripheral serotonin in the regulation of central sleep apneas in rats. Chest 115 (1999) 1397-1401
13. Carley D.W., Trbovic S., and Radulovacki M. Losartan, an angiotensin AT1 receptor antagonist, modulated sleep apnea expression in spontaneously hypertensive (SHR) rats. Sleep Res. Online 4 (2001) 7-12
14. Clozel J.P., Pisarri T.E., Coleridge H.M., and Coleridge J.C. Reflex coronary vasodilation evoked by chemical stimulation of cardiac afferent vagal C fibres in dogs. J. Physiol. 428 (1990) 215-232
15. Dun N.J., Wu S.Y., and Lin C.W. Excitatory effects of cholecystokinin octapeptide on rat nodose ganglion cells in vitro. Brain Res. 556 (1991) 161-164
16. Dunin-Barkowski W.L., and Orem J.M. Suppression of diaphragmatic activity during spontaneous ponto-geniculo-occipital waves in cat. Sleep 21 (1998) 671-675
17. El-Ad B., and Lavie P. Effect of sleep apnea on cognition and mood. Int. Rev. Psychiatry 17 (2005) 277-282
18. 3 receptors in rat nodose ganglion neurons. J. Neurophysiol. 73 (1995) 907-910
19. 3 drugs injected into the XII nucleus and vena cava in the rat. Sleep 24 (2001) 871-878
20. Hedner J., Hedner T., and Jonason J. Capsaicin and regulation of respiration: interaction with central substance P mechanisms. J. Neural Transm. 61 (1985) 239-252
21. Holtmann G., Goebell H., Jockenhoevel F., and Talley N.J. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut 42 (1998) 501-506
22. Jordan A.S., and White D.P. Pharyngeal motor control and the pathogenesis of obstructive sleep apnea. Respir. Physiol. Neurobiol. 160 (2008) 1-7
23. 3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species. Eur. J. Pharmacol. 159 (1989) 157-164
24. Kubin L., Alheid G.F., Zuperku E.J., and McCrimmon D.R. Central pathways of pulmonary and lower airway vagal afferents. J. Appl. Physiol. 101 (2006) 618-627
25. Lee L.Y., and Morton R.F. Pulmonary chemoreflex sensitivity is enhanced by prostaglandin E2 in anesthetized rats. J. Appl. Physiol. 79 (1995) 1679-1686
26. Lugaresi E., Coccagna G., and Montovani M. Hypersomnia with periodic apneas. In: Weitzman E. (Ed). Advances in Sleep Research (1978), Spectrum Publications, New York 68-70
27. Martins A.B., Tufik S., and Moura S.M. Physiopathology of obstructive sleep apnea-hypopnea syndrome. J. Bras. Pneumol. 33 (2007) 93-100
28. Millman R.P., Knight H., Kline L.R., Shore E.T., Chung D.C., and Pack A.I. Changes in compartmental ventilation in association with eye movements during REM sleep. J. Appl. Physiol. 65 (1988) 1196-1202
29. Mohammed S.P., Higenbottam T.W., and Adcock J.J. Effects of aerosol-applied capsaicin, histamine and prostaglandin E2 on airway sensory receptors of anaesthetized cats. J. Physiol. 469 (1993) 51-66
30. Nishino T. Physiological and pathophysiological implications of upper airway reflexes in humans. Jpn. J. Physiol. 50 (2000) 3-14
31. Onal E., Burrows D.L., Hart R.H., and Lopata M. Induction of periodic breathing during sleep causes upper airway obstruction in humans. J. Appl. Physiol. 61 (1986) 1438-1443
32. Parati G., Lombardi C., and Narkiewicz K. Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 (2007) R1671-1683
33. Pertwee R.G. Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors. Life Sci. 65 (1999) 597-605
34. Radulovacki M., Pavlovic S., Rakic A., Janelidze M., Shermulis L., and Carley D. Ketanserin, a 5-HT2 receptor antagonist, reduces sleep apneas in rats. Res. Commun. Biol. Psychol. Psychiatry 26 (2002) 3-14
35. 3-receptor antagonist GR 38032F suppresses sleep apneas in rats. Sleep 21 (1998) 131-136
36. Saunamaki T., and Jehkonen M. Depression and anxiety in obstructive sleep apnea syndrome: a review. Acta Neurol. Scand. 116 (2007) 277-288
37. Skatrud J.B., and Dempsey J.A. Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J. Appl. Physiol. 55 (1983) 813-822
38. Stradling J., Smith D., Radulovacki M., and Carley D. Effect of ondansetron on moderate obstructive sleep apnoea, a single night, placebo-controlled trial. J. Sleep Res. 12 (2003) 169-170
39. Szallasi A. Vanilloid receptor ligands: hopes and realities for the future. Drugs Aging 18 (2001) 561-573
40. Szallasi A., and Blumberg P.M. Vanilloid receptors: new insights enhance potential as a therapeutic target. Pain 68 (1996) 195-208
41. Thach B.T. Maturation of cough and other reflexes that protect the fetal and neonatal airway. Pulm. Pharmacol. Ther. 20 (2007) 365-370
42. Thorpy M. Obstructive sleep apnea syndrome is a risk factor for stroke. Curr. Neurol. Neurosci. Rep. 6 (2006) 147-148
43. Trbovic S.M., Radulovacki M., and Carley D.W. Protoveratrines A and B increase sleep apnea index in Sprague-Dawley rats. J. Appl. Physiol. 83 (1997) 1602-1606
44. Van Der Stelt M., and Di Marzo V. Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur. J. Biochem. 271 (2004) 1827-1834
45. Veasey S.C., Chachkes J., Fenik P., and Hendricks J.C. The effects of ondansetron on sleep-disordered breathing in the English bulldog. Sleep 24 (2001) 155-160
46. Warner G., Skatrud J.B., and Dempsey J.A. Effect of hypoxia-induced periodic breathing on upper airway obstruction during sleep. J. Appl. Physiol. 62 (1987) 2201-2211
47. Webb P. Perodic breathing during sleep. J. Appl. Physiol. 37 (1974) 899-903
48. Yoshioka M., Goda Y., and Togashi H. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat. J. Pharmacol. Exp. Ther. 260 (1992) 917-924
49. Young T., Evans L., Finn L., and Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 20 (1997) 705-706
50. Young T., Palta M., Dempsey J., Skatrud J., Weber S., and Badr S. The occurrence of sleep-disordered breathing among middle-aged adults [see comments]. N. Engl. J. Med. 328 (1993) 1230-1235
51. Zhuo H., Ichikawa H., and Helke C.J. Neurochemistry of the nodose ganglion. Prog. Neurobiol. 52 (1997) 79-107